New York State Common Retirement Fund’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.21M | Buy |
166,472
+24,100
| +17% | +$754K | 0.01% | 1053 |
|
|
2025
Q1 | $4.78M | Buy |
142,372
+9,851
| +7% | +$331K | 0.01% | 1074 |
|
|
2024
Q4 | $5.2M | Hold |
132,521
| – | – | 0.01% | 1091 |
|
|
2024
Q3 | $5.22M | Sell |
132,521
-18,319
| -12% | -$721K | 0.01% | 1083 |
|
|
2024
Q2 | $5.88M | Sell |
150,840
-41,912
| -22% | -$1.63M | 0.01% | 1050 |
|
|
2024
Q1 | $8.3M | Buy |
192,752
+2,440
| +1% | +$105K | 0.01% | 896 |
|
|
2023
Q4 | $8.77M | Buy |
190,312
+5,680
| +3% | +$262K | 0.01% | 892 |
|
|
2023
Q3 | $6.31M | Buy |
184,632
+1
| +0% | +$34 | 0.01% | 1014 |
|
|
2023
Q2 | $7.11M | Buy |
184,631
+164,952
| +838% | +$6.35M | 0.01% | 1021 |
|
|
2023
Q1 | $704K | Buy |
19,679
+3,029
| +18% | +$108K | ﹤0.01% | 2002 |
|
|
2022
Q4 | $657K | Buy |
16,650
+650
| +4% | +$25.6K | ﹤0.01% | 2185 |
|
|
2022
Q3 | $578K | Hold |
16,000
| – | – | ﹤0.01% | 2267 |
|
|
2022
Q2 | $487K | Buy |
16,000
+4,500
| +39% | +$137K | ﹤0.01% | 2378 |
|
|
2022
Q1 | $352K | Buy |
11,500
+3,400
| +42% | +$104K | ﹤0.01% | 2565 |
|
|
2021
Q4 | $253K | Buy |
+8,100
| New | +$253K | ﹤0.01% | 2781 |
|